Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will present a corporate presentation at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 p.m. PT in San Francisco, CA.
Related news for (CMRX)
- Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
- 24/7 Market News Snapshot 05 March, 2025 – Chimerix, Inc. (NASDAQ:CMRX)
- Breaking News: MoBot’s Latest Update as of 03/05/25 08:00 AM
- Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/05/25 07:00 AM